Cargando…
N1-methylpseudouridine found within COVID-19 mRNA vaccines produces faithful protein products
Synthetic mRNA technology is a promising avenue for treating and preventing disease. Key to the technology is the incorporation of modified nucleotides such as N1-methylpseudouridine (m1Ψ) to decrease immunogenicity of the RNA. However, relatively few studies have addressed the effects of modified n...
Autores principales: | Kim, Kyusik Q., Burgute, Bhagyashri D., Tzeng, Shin-Cheng, Jing, Crystal, Jungers, Courtney, Zhang, Junya, Yan, Liewei L., Vierstra, Richard D., Djuranovic, Sergej, Evans, Bradley S., Zaher, Hani S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s).
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376333/ https://www.ncbi.nlm.nih.gov/pubmed/35988540 http://dx.doi.org/10.1016/j.celrep.2022.111300 |
Ejemplares similares
-
Modulation of miRISC-Mediated Gene Silencing in Eukaryotes
por: Jungers, Courtney F., et al.
Publicado: (2022) -
N
(1)-Methylpseudouridine substitution enhances the performance of synthetic mRNA switches in cells
por: Parr, Callum J C, et al.
Publicado: (2020) -
Interactions between the mRNA and Rps3/uS3 at the entry tunnel of the ribosomal small subunit are important for no-go decay
por: Simms, Carrie L., et al.
Publicado: (2018) -
Modifications in an Emergency: The Role of N1-Methylpseudouridine
in COVID-19 Vaccines
por: Nance, Kellie D., et al.
Publicado: (2021) -
Oxidation and alkylation stresses activate ribosome-quality control
por: Yan, Liewei L., et al.
Publicado: (2019)